EQS Newswire / 24/06/2026 / 12:30 CET/CEST
41 native tech corporations, institutes and college spin-offs head to San Diego to forge international partnerships, reinforcing town’s standing as worldwide healthcare innovation hub
HONG KONG SAR/SAN DIEGO, UNITED STATES – Media OutReach Newswire – 24 June 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with InvestHK as co-organiser, the Hong Kong Trade Development Council (HKTDC) as supporting organisation, and 5 famend native universities – The University of Hong Kong, The Chinese University of Hong Kong, The Hong Kong University of Science and Technology, The Hong Kong Polytechnic University and City University of Hong Kong – to kind town’s largest-ever delegation of life and well being know-how innovators to the BIO International Convention 2026 (BIO 2026) in San Diego, from June 22 to 25.
 |
| In collaboration with InvestHK and HKTDC, HKSTP led a delegation of 41 park firms, institutes and spin-offs from 5 famend native universities to showcase the Hong Kong’s life and well being know-how improvements at BIO 2026 in San Diego. |
Building on final yr’s momentum, the 2026 Hong Kong delegation doubled the scale of the Hong Kong Pavilion, increasing to a report of 41 organisations from HKSTP, together with companion firms, analysis institutes, and for the primary time with prime 5 universities spin-offs. This landmark presence showcased Hong Kong’s deep energy throughout AI-enabled biotech, therapeutics, diagnostics, and pharma innovation, with potential excellent “First-in-Class” and “Best-in-Class” belongings. The delegation underscores town’s main position as Asia’s largest and the world’s second largest fundraising hub for the biotechnology sector.
Mr. Terry Wong, CEO of HKSTP, mentioned, “BIO 2026 is a premier platform to showcase Hong Kong’s groundbreaking innovation, deepen partnerships, and open new pathways into global healthcare markets. As a super-connector, Hong Kong is uniquely positioned to bridge global innovators with opportunities across Asia and beyond. With strong R&D capabilities backed by world-class universities-five ranked among the QS Top 100, including two with medical schools now placed in the global top 20-Hong Kong’s biotech and medical research excellence is increasingly recognised worldwide. As the city’s innovation ecosystem orchestrator, HKSTP brings together talent, capital, research institutions, clinical partners, and industry leaders to accelerate the journey from discovery to impact. We will continue to empower life and health technology ventures, translating innovation breakthroughs into life-changing solutions that benefit communities around the world.”
HKSTP and Park Companies Advanced in Cross-border Innovation and Market Expansion
A key spotlight of BIO 2026 is witnessing the signing of three main strategic partnerships:
- LabCentral — HKSTP signed an MOU withone of many largest international non–revenue biotech incubators, supporting life sciences startups with high-impact lab infrastructure and scientific neighborhood programmes. The collaboration will deepen ties between the U.S. and Hong Kong life sciences ecosystems by way of startup help, ecosystem engagement, and co-developed programmes, occasions and strategic initiatives. It may even assist join startups, buyers, company companions and analysis establishments, creating stronger pathways for cross-border innovation and commercialisation.
- Immuno Cure – the developer of the first-in-human novel therapeutic HIV vaccine ICVAX – introduced its collaboration with OPIS, a world Contract Research Organization (CRO), at BIO 2026. Leveraging OPIS’s full-service, multi-country medical trial experience and regulatory information, the partnership will help abroad medical trial execution and set up a worldwide framework to put together for worldwide growth.
- Zhaoke Ophthalmology signed an MOU with Laboratório Teuto, the primary firm to produce generic medicines and OTCs (Over the Counter – Prescription Exempt Medicines) in Brazil, to discover cross-border cooperation in ophthalmology. This is Zhaoke’s first strategic MOU in Brazil market. Leveraging its modern pipeline and Teuto’s business community in Brazil, the partnership goals to deliver superior eye care therapies to Latin American sufferers whereas demonstrating the globalisation of Hong Kong-born biotech innovation.
Beyond the BIO 2026 Hong Kong Pavilion, HKSTP CEO Mr Terry Wong attended the “Translating Innovation Across Borders: Creating Global Gateways for Biotech Startups” panel sharing session. Mr. Wong shared his insights on cutting-edge biotech tendencies, Hong Kong’s strengths on life and well being tech growth, and HKSTP’s position in constructing a worldwide bridge for nurturing international startup growth, sustainable innovation and collaboration.
Furthermore, HKSTP and 5 Hong Kong college delegates visited the Salk Institute, dwelling to six Nobel Laureates throughout BIO 2026 to discover partnerships and form international biotech momentum by way of collaborative platforms. HKSTP, in collaboration with InvestHK as co-organiser, HKTDC because the supporting organisation, and powered by the Hong Kong Economic and Trade Office in San Francisco, hosted a Global Mixer in the course of the exhibition. Industry leaders, incubators, and enterprise capital corporations – together with Bayer Pharmaceuticals, Johnson & Johnson Innovation, LabCentral, Roche, Simcere Pharmaceutical, and T.Rx Capital – have been invited to be a part of the judging panel for startup pitching classes. The Pavilion additionally featured government sharing and curated networking occasions for commercialisation, licensing, partnerships, funding and worldwide market growth.
Global recognition at Biomedical Pitch Competition
In the lead-up to BIO 2026, HKSTP actively drove engagement throughout the biotech sector and co-organised the 2026 Biomedical Pitch Competition with the Boston Capital Investment Club in Boston on May 23 and 24. Competing in opposition to round 170 biotechnology firms worldwide, HKSTP park firm Meta Pharmaceuticals (HK) Limited received Third Place for its next-generation autoimmune therapeutics. The recognition underscores the energy of Hong Kong’s biotech pipeline and HKSTP’s dedication to translational medication, commercialisation and globally scalable healthcare options.
HK’s biotech ecosystem rises to one other degree
Hong Kong continues to increase its international healthcare footprint because the world’s second-largest biotech fundraising hub. As Hong Kong’s flagship innovation and know-how ecosystem, HKSTP is dwelling to greater than 300 life and well being know-how firms and helps innovators flip pioneering concepts into real-world influence. Its ecosystem connects capital, expertise, infrastructure and market entry throughout the biotech innovation journey.
Hashtag: HKSTP
The issuer is solely chargeable for the content material of this announcement.
Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, greater than 17,000 analysis professionals and over 2,500 know-how firms from 26 nations and areas centered on growing healthtech, AI and robotics, fintech and sensible metropolis applied sciences, and so forth.
Our rising innovation ecosystem affords complete help to entice and nurture expertise, speed up and commercialise innovation for know-how ventures, with the I&T journey constructed round our key areas of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three trendy InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a imaginative and prescient of recent industrialisation for Hong Kong, the place sectors together with superior manufacturing, micro-electronics and biotechnology are being reimagined.
Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen performs optimistic roles in connecting the world and the mainland with our proximity, strengthening cross-border change to deliver benefits in attracting international expertise and permitting potentialities for the event of know-how firms in seven key areas: Medtech, huge information and AI, robotics, new supplies, microelectronics, fintech and sustainability, with each dry and moist laboratories, co-working house, convention and exhibition services, and extra.
Through our R&D infrastructure, startup help and enterprise providers, commercialisation and funding experience, partnership networks and expertise traction, HKSTP continues to contribute in establishing I&T as a pillar of progress for Hong Kong.
More details about HKSTP is accessible at www.hkstp.org.
News Source: Hong Kong Science and Technology Parks Corporation
24/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.
The issuer is solely chargeable for the content material of this announcement.
Media archive at www.todayir.com
View unique content material: EQS News